Brussels, 18/04/2013 (Agence Europe) - On 16 April, the European Medicines Agency (EMA) published its annual report. It reveals the growing complexity of authorisation requests received, the rise in demand for orphan medicines and the rise in demand from SMEs.
According to the annual report, the number of requests EMA received last year for marketing authorisation approval (MAA) for medicines destined for human use remained stable, with a total of 96 requests. The EMA human scientific...